home / stock / awkn:cc / awkn:cc news

AWKN:CC News and Press, AWAKN LIFE SCIENCES CORP. From 07/05/22

Stock Information
Company Name: AWAKN LIFE SCIENCES CORP.
Stock Symbol: AWKN:CC
Market: AQNC
Website: awaknlifesciences.com
Menu
AWKN:CC AWKN:CC Quote AWKN:CC Short AWKN:CC News AWKN:CC Articles AWKN:CC Message Board
Get AWKN:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
AWKN:CC - Awakn Life Sciences Receives UK State Funding to Identify Optimal Pathway to Market in UK & US for Its Lead Clinical Development Program - Ketamine-Assisted Therapy for Alcohol Use Disorder

Awakn Provides Business Update on Progressing its Lead Program from Phase II b to Phase III Toronto, Ontario--(Newsfile Corp. - July 5, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954), a revenue-generating biotechnology company researching, developing and commercializi...
AWKN:CC - Awakn Life Sciences to Present in Upcoming June 2022 Conferences

Toronto, Ontario--(Newsfile Corp. - June 17, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a revenue-generating biotechnology company researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder...

AWKN:CC - Awakn Life Sciences Reports Results for Quarter Ended April 30, 2022

Awakn delivered revenue growth of 24% in the quarter Toronto, Ontario--(Newsfile Corp. - June 14, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company, researching, developing, and commercializing therapeutics to treat addiction with a n...

AWKN:CC - Awakn Life Sciences Appoints Biotech and Investment Veteran Dennis Purcell as a Special Advisor to the CEO

Seasoned Leader Brings Deep Knowledge of US Biotech Market to Awakn Toronto, Ontario--(Newsfile Corp. - June 7, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company, researching, developing, and commercializing therapeutics to treat addict...
AWKN:CC - Awakn Life Sciences Initiates Follow-On Behavioral Study to Focus on Gambling Disorder

Study Initiated Following Recent Successful Pilot Study and Patent Filing Toronto, Ontario--(Newsfile Corp. - June 2, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company, researching, developing, and commercializing therapeutics to treat ...

AWKN:CC - Awakn Life Sciences Files Patent Cooperation Treaty (PCT) Application for the Treatment of Behavioral Addictions

Successful Behavioral Addiction Study Supplied Data for Patent Toronto, Ontario--(Newsfile Corp. - May 26, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company, researching, developing, and commercializing therapeutics to treat addiction, ...

AWKN:CC - Awakn Life Sciences CEO, Anthony Tennyson, Joins Dustin Robinson of Iter Investments for 'The Investor Hotseat' via Live Stream on May 26th

Toronto, Ontario--(Newsfile Corp. - May 24, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company, researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), is pleased ...
AWKN:CC - Awakn Life Sciences Completes World's First Ketamine Treatment Study for a Range of Behavioral Addictions

Promising Results Merit Larger Study Which Awakn is Initiating Toronto, Ontario--(Newsfile Corp. - May 19, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company, researching, developing, and commercializing therapeutics to treat addiction w...

AWKN:CC - Awakn Life Sciences Appoints UK Leader in Addictions Psychiatry, Dr. Arun Dhandayudham, as Chief Medical Officer

Dr. Dhandayudham Brings Significant Frontline Addiction and Mental Health Medical Leadership Experience to Awakn Toronto, Ontario--(Newsfile Corp. - May 17, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company, researching, developing, and...

AWKN:CC - Awakn Life Sciences to Participate in Upcoming May 2022 Conferences

Toronto, Ontario--(Newsfile Corp. - May 5, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company, researching, developing, and delivering combined therapeutics to treat addiction, announced today that Awakn's management team is scheduled to ...
Previous 10 Next 10